Company / Corporate

Veracyte.

Follow Veracyte

SEC classifies Veracyte under Services-Medical Laboratories (SIC 8071).[1]

01Deal
01

Deals on Carrywatch

Every deal that names Veracyte, and its role in each.

Veracyte / C2i Genomics

Veracyte agrees to buy C2i Genomics

See deal details
02

Deal Web

Veracyte and 0 firms it shares a posted deal with, and the path to any other firm.

03

Financials

5 fiscal years of figures as Veracyte reported them.

04

News

Loading headlines.

05

Sources

As of 24 Oct 2026.

  1. 01
    SEC EDGAR company record for VERACYTE, INC.

    U.S. Securities and Exchange Commission · Researched 24 Oct 2026

  2. 02
    Form 8-K Current Report, February 5, 2024

    U.S. Securities and Exchange Commission · Researched 24 Oct 2026

Deal posts naming Veracyte:

  1. P01